134 related articles for article (PubMed ID: 12405632)
1. The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions.
Borjesson DL; Barthold SW
Comp Med; 2002 Oct; 52(5):403-13. PubMed ID: 12405632
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis.
Borjesson DL; Simon SI; Tablin F; Barthold SW
J Infect Dis; 2001 Dec; 184(11):1475-9. PubMed ID: 11709793
[TBL] [Abstract][Full Text] [Related]
3. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model.
Martin ME; Bunnell JE; Dumler JS
J Infect Dis; 2000 Jan; 181(1):374-8. PubMed ID: 10608792
[TBL] [Abstract][Full Text] [Related]
4. A case of equine granulocytic ehrlichiosis provides molecular evidence for the presence of pathogenic anaplasma phagocytophilum (HGE agent) in Germany.
Von Loewenich FD; Stumpf G; Baumgarten BU; Röllinghoff M; Dumler JS; Bogdan C
Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):303-5. PubMed ID: 12740667
[TBL] [Abstract][Full Text] [Related]
5. Infection with Anaplasma phagocytophila in cervids from Slovenia: evidence of two genotypic lineages.
Petrovec M; Bidovec A; Sumner JW; Nicholson WL; Childs JE; Avsic-Zupanc T
Wien Klin Wochenschr; 2002 Jul; 114(13-14):641-7. PubMed ID: 12422618
[TBL] [Abstract][Full Text] [Related]
6. [Ixodes ricinus, transmitted diseases and reservoirs].
Rizzoli A; Rosà R; Mantelli B; Pecchioli E; Hauffe H; Tagliapietra V; Beninati T; Neteler M; Genchi C
Parassitologia; 2004 Jun; 46(1-2):119-22. PubMed ID: 15305699
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the human granulocytic ehrlichiosis agent based on analysis of rRNA isolated from control and infected HL-60 cells.
Wu JM; Whyzmuzis CA; Bertone MG; Zhou BS; Hsieh TC
Biochem Biophys Res Commun; 1999 Aug; 262(1):7-13. PubMed ID: 10448059
[TBL] [Abstract][Full Text] [Related]
8. Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE).
Hsieh TC; Aguero-Rosenfeld ME; Wu JM; Ng C; Papanikolaou NA; Varde SA; Schwartz I; Pizzolo JG; Melamed M; Horowitz HW; Nadelman RB; Wormser GP
Biochem Biophys Res Commun; 1997 Mar; 232(2):298-303. PubMed ID: 9125168
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological, clinical and laboratory distinction between human granulocytic ehrlichiosis and the initial phase of tick-borne encephalitis.
Lotric-Furlan S; Petrovec M; Avsic-Zupanc T; Logar M; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):636-40. PubMed ID: 12422617
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis.
Bayard-Mc Neeley M; Bansal A; Chowdhury I; Girao G; Small CB; Seiter K; Nelson J; Liveris D; Schwartz I; Mc Neeley DF; Wormser GP; Aguero-Rosenfeld ME
J Clin Pathol; 2004 May; 57(5):499-503. PubMed ID: 15113857
[TBL] [Abstract][Full Text] [Related]
11. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis.
Bakken JS; Dumler JS
Ann N Y Acad Sci; 2006 Oct; 1078():236-47. PubMed ID: 17114714
[TBL] [Abstract][Full Text] [Related]
12. Tick-borne ehrlichiosis infection in human beings.
Ganguly S; Mukhopadhayay SK
J Vector Borne Dis; 2008 Dec; 45(4):273-80. PubMed ID: 19248653
[TBL] [Abstract][Full Text] [Related]
13. Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system.
Bunnell JE; Trigiani ER; Srinivas SR; Dumler JS
J Infect Dis; 1999 Aug; 180(2):546-50. PubMed ID: 10395880
[TBL] [Abstract][Full Text] [Related]
14. Experimental infection of C3H/HeJ mice with the NY18 isolate of Anaplasma phagocytophilum.
Blas-Machado U; de la Fuente J; Blouin EF; Almazán C; Kocan KM; Mysore JV
Vet Pathol; 2007 Jan; 44(1):64-73. PubMed ID: 17197625
[TBL] [Abstract][Full Text] [Related]
15. Human ehrlichiosis in central Europe.
Lotric-Furlan S; Petrovec M; Avsic-Zupanc T; Nicholson WL; Sumner JW; Childs JE; Strle F
Wien Klin Wochenschr; 1998 Dec; 110(24):894-7. PubMed ID: 10048172
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of human granulocytic ehrlichiosis in children using rifampin.
Krause PJ; Corrow CL; Bakken JS
Pediatrics; 2003 Sep; 112(3 Pt 1):e252-3. PubMed ID: 12949322
[TBL] [Abstract][Full Text] [Related]
17. New findings on anaplasmosis caused by infection with Anaplasma phagocytophilum.
Lillini E; Macrì G; Proietti G; Scarpulla M
Ann N Y Acad Sci; 2006 Oct; 1081():360-70. PubMed ID: 17135539
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of granulocytic anaplasmosis and infectious cyclic thrombocytopenia by PCR-RFLP.
Alberti A; Sparagano OA
Ann N Y Acad Sci; 2006 Oct; 1081():371-8. PubMed ID: 17135540
[TBL] [Abstract][Full Text] [Related]
19. Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis.
Lotric-Furlan S; Petrovec M; Avsic-Zupanc T; Strle F
Scand J Infect Dis; 2004; 36(11-12):817-22. PubMed ID: 15764167
[TBL] [Abstract][Full Text] [Related]
20. Human granulocytic anaplasmosis.
Bakken JS; Dumler S
Infect Dis Clin North Am; 2008 Sep; 22(3):433-48, viii. PubMed ID: 18755383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
